JETABLE Launches "JET-LAG-SPRAY" For Effective Travel Fatigue Protection; That Helps Boost Natural Immunity

JETABLE INTERNATIONAL, INC., announced today the official launch of a new medicated anti-fatigue travel remedy called; JET-LAG-SPRAY. In the future Airline flight crews and frequent flyers might improve their mental and physical sharpness using a potassium iodide-based electrolyte anti-fatigue oral spray. The results of a prospective clinical study suggest that JET-LAG-SPRAY can be used as a safe and effective alternative to conventional Airport Kiosk homeopathic formulations such as "No-Jet-Lag" or "JetLagFX" used to remain focused and alert during long-haul international flights. JET-LAG-SPRAY helps boost natural immunity, protecting against harmful radioactive iodine, colds, and the flu bug.

JET-LAG-SPRAY is a special blend of Potassium Iodide and bioactive compounds that are designed to help maintain one's immune system naturally. Airline travel across multiple time zones produces jet lag, which includes difficulty initiating or maintaining nighttime sleep, daytime sleepiness, decreased alertness, loss of concentration, impaired performance, fatigue, irritability, disorientation, depressed mood, and gastrointestinal disturbance. Jet lag poses a threat to public safety as it affects civilian and military pilots.

"With Airport Kiosk product placement, we are able to increase last-minute impulse purchases of JET-LAG-SPRAY, bought by frequent flyers about to board international long-haul flights," said Richard H, DAVIS, Président Directeur Général de JETABLE INTERNATIONAL, INC. "No one ever plans ahead for jet lag prevention, Air Travelers just buy the product when they see it," said DAVIS.

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

To find out more, visit: https://jetable.webnode.co.uk

Richard H, DAVIS
Président Directeur Général
JETABLE INTERNATIONAL, INC.
2 RUE DES ARCHIVES, 75004 PARIS
Tel: +33 7 5713 0799 | investors@jetable.fr.nf
https://jetable.webnode.co.uk

JETABLE INTERNATIONAL, INC., is a leading biotechnology company focused on the discovery, development, and commercialization of novel biomedical technologies to address cognitive issues in neurodegenerative diseases and other age-related aspects of aging and memory loss.

This release was published on openPR.